OABI
Price
$1.93
Change
+$0.07 (+3.76%)
Updated
Jul 3 closing price
Capitalization
236.11M
VIGL
Price
$7.99
Change
+$0.01 (+0.13%)
Updated
Jul 3 closing price
Capitalization
372.91M
37 days until earnings call
Interact to see
Advertisement

OABI vs VIGL

Header iconOABI vs VIGL Comparison
Open Charts OABI vs VIGLBanner chart's image
OmniAb
Price$1.93
Change+$0.07 (+3.76%)
Volume$234.38K
Capitalization236.11M
Vigil Neuroscience
Price$7.99
Change+$0.01 (+0.13%)
Volume$421.41K
Capitalization372.91M
OABI vs VIGL Comparison Chart in %
Loading...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OABI vs. VIGL commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OABI is a Hold and VIGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (OABI: $1.93 vs. VIGL: $7.99)
Brand notoriety: OABI and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OABI: 23% vs. VIGL: 30%
Market capitalization -- OABI: $236.11M vs. VIGL: $372.91M
OABI [@Biotechnology] is valued at $236.11M. VIGL’s [@Biotechnology] market capitalization is $372.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OABI’s FA Score shows that 1 FA rating(s) are green whileVIGL’s FA Score has 0 green FA rating(s).

  • OABI’s FA Score: 1 green, 4 red.
  • VIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both OABI and VIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OABI’s TA Score shows that 4 TA indicator(s) are bullish while VIGL’s TA Score has 4 bullish TA indicator(s).

  • OABI’s TA Score: 4 bullish, 5 bearish.
  • VIGL’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than OABI.

Price Growth

OABI (@Biotechnology) experienced а +14.20% price change this week, while VIGL (@Biotechnology) price change was +0.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

OABI is expected to report earnings on May 08, 2025.

VIGL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($373M) has a higher market cap than OABI($236M). VIGL YTD gains are higher at: 370.000 vs. OABI (-45.480). OABI has higher annual earnings (EBITDA): -47.42M vs. VIGL (-91.27M). VIGL has more cash in the bank: 87.1M vs. OABI (43.6M). VIGL has less debt than OABI: VIGL (12.7M) vs OABI (22.5M). OABI has higher revenues than VIGL: OABI (26.7M) vs VIGL (0).
OABIVIGLOABI / VIGL
Capitalization236M373M63%
EBITDA-47.42M-91.27M52%
Gain YTD-45.480370.000-12%
P/E RatioN/AN/A-
Revenue26.7M0-
Total Cash43.6M87.1M50%
Total Debt22.5M12.7M177%
TECHNICAL ANALYSIS
Technical Analysis
OABIVIGL
RSI
ODDS (%)
Bearish Trend 3 days ago
42%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
46%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRCOF349.00N/A
N/A
Fast Retailing Co. Ltd.
SILLF0.15N/A
N/A
Sarin Technologies Ltd.
ALFNF15.20N/A
N/A
Alfen NV
EDVGF2.71N/A
N/A
ENDEAVOUR GROUP LTD.
FMELF0.01N/A
-5.04%
FUTURE METALS NL

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with BEAM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+3.76%
BEAM - OABI
39%
Loosely correlated
+0.65%
NTLA - OABI
38%
Loosely correlated
+0.09%
IMNM - OABI
38%
Loosely correlated
+2.43%
ALEC - OABI
37%
Loosely correlated
+6.34%
VIGL - OABI
37%
Loosely correlated
+0.13%
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with MRUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
+0.13%
MRUS - VIGL
49%
Loosely correlated
+0.92%
IMNN - VIGL
47%
Loosely correlated
-1.24%
OABI - VIGL
37%
Loosely correlated
+3.76%
ELVN - VIGL
36%
Loosely correlated
+0.44%
RCKT - VIGL
36%
Loosely correlated
+0.69%
More